Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Decitabine as Induction Therapy for Acute Myeloid Leukemia With Complex and/or Monosomal Karyotype

NCT03080766 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT03080766
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03080766 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Decitabine as Induction Therapy for Acute Myeloid Leukemia With Complex and/or Monosomal Karyotype
Lead sponsor
The University of Hong Kong
Phase
Phase 2
Overall status
Unknown status
Start date
March 1, 2017
Completion date
December 28, 2021
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia, complex karyotype